US may not even need AstraZeneca COVID-19 vaccine, says Fauci



[ad_1]

The United States may not need AstraZeneca’s coronavirus vaccine – even though the vaccine is approved by federal regulators, Dr Anthony Fauci said Thursday.

In an interview with Reuters, Fauci, the White House’s chief medical adviser, said the country already has enough contracts with other vaccine makers to vaccinate the entire population.

“My general feeling is that given the contractual relationships we have with a number of companies, we have enough vaccines to meet all of our needs without resorting to AstraZeneca,” he said.

The nation’s top infectious disease expert added that the United States may have enough vaccines for booster shots in the fall.

“If you look at the numbers (of doses) we’re going to get… it’s likely that we can handle any boost we need, but I can’t say for sure,” he told Reuters .

A vial of AstraZeneca vaccine, inside the vaccine preparation room of the vaccination center in the pheasant room of the Capodimonte museum.
AstraZeneca’s COVID-19 vaccine has yet to be approved in the United States.
Marco Cantile / LightRocket via Getty Images

Once hailed as a breakthrough in the fight against COVID-19, AstraZeneca’s shooting has been under surveillance since late last year.

Last month, more than a dozen countries that had approved the London-based pharmaceutical company’s vax temporarily suspended its use after reports linked it to a rare blood clotting disorder.

Meanwhile, US regulators accused the company of “gathering data” to make the shot appear more effective.

Following public criticism, AstraZeneca said the data was based on a “pre-specified interim analysis” and agreed to release an updated report.

The company then released revised results showing decreased, although still strong, efficacy for its inoculation.

Dr Anthony Fauci listens to US President Joe Biden on a tour of the National Institutes of Health.
Dr Anthony Fauci listens to US President Joe Biden speak while touring the National Institutes of Health.
Oliver Contreras / Sipa / Bloomberg via Getty Images

AstaZeneca also said it plans to seek emergency use clearance from the FDA for the vaccine in a few weeks.

With pole wires

,

[ad_2]

Source link